Filtros de búsqueda

Lista de obras de Daniele Pastori

ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study

artículo científico publicado en 2019

ATHEROTHROMBOSIS AND OXIDATIVE STRESS: MECHANISMS AND MANAGEMENT IN ELDERLY.

artículo científico

Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation

scientific article published on 06 June 2016

Aging and Adherence to the Mediterranean Diet: Relationship with Cardiometabolic Disorders and Polypharmacy.

artículo científico publicado en 2018

Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation.

artículo científico publicado en 2016

Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study.

artículo científico publicado en 2016

Anoxia-Reoxygenation Enhances Platelet Thromboxane A 2 Production via Reactive Oxygen Species–Generated NOX2

article

Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding.

artículo científico publicado en 2016

Antioxidant activity from extra virgin olive oil via inhibition of hydrogen peroxide-mediated NADPH-oxidase 2 activation

artículo científico publicado en 2018

Antioxidant and antiplatelet effects of atorvastatin by Nox2 inhibition

artículo científico

Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis

artículo científico

Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis

scientific article published on 09 June 2020

Antiphospholipid syndrome and anticoagulation quality: a clinical challenge.

artículo científico publicado en 2015

Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease

artículo científico publicado en 2016

Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: a multicentre cohort study ⬇️

artículo científico publicado en 2020

Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms

artículo científico publicado en 2016

Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy

scientific article published on 11 January 2019

Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study

artículo científico publicado en 2020

Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices

artículo científico publicado en 2019

Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events

artículo científico publicado en 2018

C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.

artículo científico publicado en 2017

Cancer-specific ischemic complications in elderly patients with atrial fibrillation. Data from the prospective ATHERO-AF study

artículo científico publicado en 2020

Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score

artículo científico publicado en 2015

Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study

artículo científico publicado en 2017

Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants

artículo científico publicado en 2018

Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation

artículo científico publicado en 2013

Clinical Phenotypes of Atrial Fibrillation and Mortality Risk-A Cluster Analysis from the Nationwide Italian START Registry

artículo científico publicado en 2022

Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients

scientific article published on 16 March 2018

Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

artículo científico publicado en 2018

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.

artículo científico publicado en 2018

Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study

scientific article published on 20 February 2020

Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation

Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation

artículo científico publicado en 2014

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta-Analysis

artículo científico publicado en 2020

Direct oral anticoagulant reversal: how, when and issues faced

artículo científico publicado en 2017

Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?

artículo científico publicado en 2015

Does Mediterranean Diet Reduce Cardiovascular Events and Oxidative Stress in Atrial Fibrillation?

scholarly article by Daniele Pastori published in September 2015

Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses

artículo científico publicado en 2023

Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis

artículo científico publicado en 2017

Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy.

artículo científico publicado en 2018

Extra virgin olive oil blunt post-prandial oxidative stress via NOX2 down-regulation

artículo científico publicado en 2014

Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects.

artículo científico publicado en 2015

Features of severe COVID-19: A systematic review and meta-analysis

artículo científico publicado en 2020

Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice.

artículo científico publicado en 2018

Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients

scholarly article by Ludovica Perri et al published January 2015 in International Journal of Cardiology

Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet.

artículo científico publicado en 2017

Gut-derived lipopolysaccharides increase post-prandial oxidative stress via Nox2 activation in patients with impaired fasting glucose tolerance: effect of extra-virgin olive oil

scientific article published on 16 May 2018

HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)

artículo científico publicado en 2020

HIV-1 induces in vivo platelet activation by enhancing platelet NOX2 activity

artículo científico publicado en 2015

Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge

artículo científico publicado en 2020

Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2.

artículo científico

Immunomodulatory effects of intravenous immunoglobulins (IVIGs) in HIV-1 disease: a systematic review.

artículo científico publicado en 2010

Immunorecovery after prolonged HIV-related immunosuppression: opportunities of the new antiretroviral classes

artículo científico publicado en 2009

Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia

artículo científico publicado en 2016

Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation

artículo científico publicado en 2015

Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.

artículo científico publicado en 2018

Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors

artículo científico publicado en 2015

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.

artículo científico publicado en 2012

Increased liver localization of lipopolysaccharides in human and experimental non-alcoholic fatty liver disease

artículo científico publicado en 2019

Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices

artículo científico publicado en 2018

Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review

artículo científico publicado en 2016

Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation: A post-hoc analysis from the ATHERO-AF cohort

artículo científico publicado en 2019

Is There an Interplay Between Adherence to Mediterranean Diet, Antioxidant Status, and Vascular Disease in Atrial Fibrillation Patients?

artículo científico publicado en 2016

Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases?

artículo científico publicado en 2013

Left Atrium Dilatation and Left Ventricular Hypertrophy Predispose to Atrial Fibrillation in Patients With Community-Acquired Pneumonia

scientific article published on 06 June 2019

Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA)

scientific article published on 01 September 2018

Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italia

article

Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production.

artículo científico publicado en 2017

Lithiasis of semicircular canals and parotid glands: unusual stones deposition in atazanavir-treated individuals.

artículo científico publicado en 2009

Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque.

artículo científico publicado en 2018

Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome

artículo científico publicado en 2018

Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose

artículo científico publicado en 2017

Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease

scientific article published on 21 August 2019

Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

artículo científico publicado en 2018

Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication ⬇️

artículo científico publicado el 1 de marzo de 2011

Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients

artículo científico publicado en 2014

Modern approach to the clinical management of non-alcoholic fatty liver disease

artículo científico publicado en 2014

New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress

scientific article published on 10 September 2020

Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants.

artículo científico publicado en 2014

Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study

scientific article published on 27 December 2019

Nox-2 up-regulation and platelet activation: Novel insights

artículo científico

Nox2-mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin

scientific article published on 13 February 2019

Nutrition, Thrombosis, and Cardiovascular Disease

scientific article published on 07 May 2020

Nutritional and therapeutic approaches to modulate NADPH oxidase-derived ROS signaling in platelets

artículo científico publicado en 2015

Off-label use of ceftaroline fosamil: A systematic review

scientific article published on 03 July 2019

Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH.

artículo científico publicado en 2018

Oxidative stress and cardiovascular disease: new insights.

artículo científico publicado en 2018

Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis

artículo científico publicado en 2015

PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress

artículo científico publicado en 2017

Pentraxin 3　– A Link Between Obesity, Inflammation and Vascular Disease? –

Quantifying time in atrial fibrillation and the need for anticoagulation

artículo científico publicado en 2017

Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease

artículo científico publicado en 2011

Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

scientific article published on 27 June 2019

Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease

artículo científico publicado en 2015

Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors

artículo científico publicado en 2015

Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists

artículo científico publicado en 2015

Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study

artículo científico publicado en 2015

Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.

artículo científico publicado en 2017

Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation

artículo científico publicado en 2017

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease

artículo científico publicado en 2018

Reply

Reply to “The relation between flow mediated dilation and atrial fibrillation” by S. Balta

artículo científico publicado en 2015

Reply to: "Monitoring antivitamin K anticoagulants in antiphospholipid syndrome: A challenge in quality"

artículo científico publicado en 2016

Reply to: “Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke”

artículo científico publicado en 2015

Reply: LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient?

artículo científico publicado en 2018

Response to Duret et al

artículo científico publicado en 2018

Response to “Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality”

Risk factors for new-onset atrial fibrillation: A focus on Asian populations.

artículo científico publicado en 2018

Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus

artículo científico publicado en 2018

Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation.

artículo científico publicado en 2014

Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study

artículo científico publicado en 2017

Severity of OSAS, CPAP and cardiovascular events: A follow-up study

artículo científico publicado en 2018

Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F2α in HIV-1 patients on abacavir-based therapies

artículo científico publicado en 2016

Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis

artículo científico publicado en 2015

Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease.

artículo científico publicado en 2017

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

scientific article published on 05 May 2020

Statins and non-alcoholic fatty liver disease

scientific article published on 10 June 2019

Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation

artículo científico publicado en 2018

The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease

artículo científico publicado en 2015

The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease

artículo científico publicado en 2016

Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation

artículo científico publicado en 2018

Total adiponectin is inversely associated with platelet activation and CHA₂DS₂-VASc score in anticoagulated patients with atrial fibrillation.

artículo científico publicado en 2014

Under-prescription of statins in patients with non-alcoholic fatty liver disease.

artículo científico publicado en 2016

Undifferentiated connective tissue disease - an unsolved problem:revision of literature and case studies

artículo científico publicado en 2010

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation

artículo científico publicado en 2015

Validation of an LC–MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma

Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study

scientific article published on 26 August 2019

Vitamin E serum levels and bleeding risk in patients receiving oral anticoagulant therapy: a retrospective cohort study

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda